Many patients are left humiliated and depressed because of the daily disruptions caused by urinary or fecal incontinence. Vermont company AugmentRX is developing incontinence solutions for the 200 million-plus people worldwide who suffer from this debilitating condition.
A new analysis of AstraZeneca’s cholesterol-lowering statin Crestor shows that the drug sharply reduces the risk of venous thromboembolism (VTE), a potentially fatal disorder in which blood clots can form in the legs and travel to the lungs.
A new experimental device to treat atrial fibrillation had mixed results in a recent study but still shows promise as a treatment option. The Watchman is the first device designed to permanently treat atrial fibrillation, a heart condition in which blood stagnates in a small pouch called the left atrial appendage.
Only 9 percent of U.S. hospitals use electronic medical records, according to a new survey. It’s a far cry from the comprehensive, high-tech environment supported by the Obama and Bush administrations.
Pathway Medical Technologies, Inc. recently announced that it has secured a $40 million Series D round of financing, reports DeviceSpace. Raising such a large amount of capital is a rare achievement for a medical device venture, particularly in today’s tough economic climate.
A new study by Abbott Laboratories found that their drug-coated stent, Xience V, is more effective in the long term than a competitor’s. According to the Wall Street Journal, the data showed that rates of major cardiovascular events plateaued at 6.4% in the second and third years after Xience was implanted.
The Medical Device Manufacturers Association (MDMA) 2009 Annual Meeting will bring together executives from innovative medical technology companies and healthcare’s most influential and respected decision makers. Please plan to join the MDMA in our Nation’s Capital for a meeting that stimulates new ideas, offers solutions and promotes innovation in the changing spectrum of medical technology.
Look out, Spider-Man. A British company has reproduced the silk that spider webs are made out of, for use in repairing bone and joint injuries. Spidrex tissue scaffolds, developed by Oxford Biomaterials, work in tandem with the body’s ability to heal itself…
It sounds like something out of a sci-fi film: microscopic robots that can be injected into the bloodstream to perform surgical procedures. This futuristic concept is closer to reality than one might think. Researchers at Australia’s Monash University have created tiny surgical microbots to treat conditions including stroke and arterial blockage.
Copyright © 2026 | WordPress Theme by MH Themes